Myasthenia gravis associated with etanercept therapy

Dominic B. Fee; Edward J. Kasarskis

doi:10.1002/mus.21280

Myasthenia gravis associated with etanercept therapy

Dominic B. Fee, Edward J. Kasarskis

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Abstract

Etanercept is an antagonist of tumor necrosis factor alpha that was developed to treat rheumatoid arthritis. In this report we present a patient who developed myasthenia gravis while taking etanercept and had resolution of symptoms after stopping it. This is the first report of this potential side effect and is of additional interest, because etanercept has been proposed as a treatment for myasthenia gravis.

Original language	English
Pages (from-to)	866-870
Number of pages	5
Journal	Muscle and Nerve
Volume	39
Issue number	6
DOIs	https://doi.org/10.1002/mus.21280
State	Published - Jun 2009

Keywords

Acetylcholine receptor antibodies
Enbrel
Etanercept
Myasthenia gravis
Pathophysiology

ASJC Scopus subject areas

Physiology
Clinical Neurology
Cellular and Molecular Neuroscience
Physiology (medical)

Access to Document

10.1002/mus.21280

Cite this

@article{fe2835b010e44992ab914b584a8f8ca4,

title = "Myasthenia gravis associated with etanercept therapy",

abstract = "Etanercept is an antagonist of tumor necrosis factor alpha that was developed to treat rheumatoid arthritis. In this report we present a patient who developed myasthenia gravis while taking etanercept and had resolution of symptoms after stopping it. This is the first report of this potential side effect and is of additional interest, because etanercept has been proposed as a treatment for myasthenia gravis.",

keywords = "Acetylcholine receptor antibodies, Enbrel, Etanercept, Myasthenia gravis, Pathophysiology",

author = "Fee, {Dominic B.} and Kasarskis, {Edward J.}",

year = "2009",

month = jun,

doi = "10.1002/mus.21280",

language = "English",

volume = "39",

pages = "866--870",

number = "6",

}

TY - JOUR

T1 - Myasthenia gravis associated with etanercept therapy

AU - Fee, Dominic B.

AU - Kasarskis, Edward J.

PY - 2009/6

Y1 - 2009/6

N2 - Etanercept is an antagonist of tumor necrosis factor alpha that was developed to treat rheumatoid arthritis. In this report we present a patient who developed myasthenia gravis while taking etanercept and had resolution of symptoms after stopping it. This is the first report of this potential side effect and is of additional interest, because etanercept has been proposed as a treatment for myasthenia gravis.

AB - Etanercept is an antagonist of tumor necrosis factor alpha that was developed to treat rheumatoid arthritis. In this report we present a patient who developed myasthenia gravis while taking etanercept and had resolution of symptoms after stopping it. This is the first report of this potential side effect and is of additional interest, because etanercept has been proposed as a treatment for myasthenia gravis.

KW - Acetylcholine receptor antibodies

KW - Enbrel

KW - Etanercept

KW - Myasthenia gravis

KW - Pathophysiology

UR - http://www.scopus.com/inward/record.url?scp=67049145696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049145696&partnerID=8YFLogxK

U2 - 10.1002/mus.21280

DO - 10.1002/mus.21280

M3 - Article

C2 - 19373885

AN - SCOPUS:67049145696

VL - 39

SP - 866

EP - 870

IS - 6

ER -

Myasthenia gravis associated with etanercept therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this